Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Investigator-Blind Trial to Evaluate the Bacteriologic Eradication, Safety and Tolerability, and Pharmacokinetics of Different Dosages of Faropenem Medoxomil BID for 10 Days in the Treatment of Acute Otitis Media

NCT00276042 is registered in ClinicalTrials.gov with Replidyne as lead sponsor.

NCT NCT00276042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00276042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Investigator-Blind Trial to Evaluate the Bacteriologic Eradication, Safety and Tolerability, and Pharmacokinetics of Different Dosages of Faropenem Medoxomil BID for 10 Days in the Treatment of Acute Otitis Media
Lead sponsor
Replidyne
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2006
Completion date
Not reported
Enrollment
328 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

otitis media